Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 314

Results For "MED"

7024 News Found

KIMS Hospitals to acquire land on 99-year lease to set up new hospital at Thane
Healthcare | March 05, 2024

KIMS Hospitals to acquire land on 99-year lease to set up new hospital at Thane

The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore


Biocon Biologics secures Canada market entry date for YESAFILI
News | March 05, 2024

Biocon Biologics secures Canada market entry date for YESAFILI

This agreement paves the way for the introduction of YESAFILI into the Canadian market


Dr Mandaviya launches AYUSH-ICMR Advanced Centre for Integrated Health Research in AIIMS
Policy | March 05, 2024

Dr Mandaviya launches AYUSH-ICMR Advanced Centre for Integrated Health Research in AIIMS

Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research


Govt.  setting up of Ayush - ICMR Advanced Centre for AI-ACIHR at select AIIMS
News | March 04, 2024

Govt. setting up of Ayush - ICMR Advanced Centre for AI-ACIHR at select AIIMS

Launch of Indian public health standards for Ayush healthcare facilities


Dr. Mandaviya addresses Governing Council Meeting of the ICMR
News | March 04, 2024

Dr. Mandaviya addresses Governing Council Meeting of the ICMR

ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research


Ami Organics granted patent
News | March 04, 2024

Ami Organics granted patent

With this, the total number of Patents granted to company for its innovative processes and technology stands at 9


Briefs: SMS Pharmaceuticals and Vimta Labs
News | March 03, 2024

Briefs: SMS Pharmaceuticals and Vimta Labs

EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility


Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease
Clinical Trials | March 03, 2024

Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease

Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg